Taiwan FDA registration 176e04456a28b0b60b6e7e1b44d8ddcc

Baynex Influenza 2-in-1 Viral Antigen Rapid Diagnostic Test Card (Unsterilized)

TW: 拜奈克思流行性感冒二合一型病毒抗原快速診斷檢驗卡(未滅菌)

Taiwan·Risk Class 1·Abbott Diagnostics Scarborough, Inc.·Registered Jul 18, 2012 – Jul 18, 2022Cancelled

Registration details

Analysis ID: 176e04456a28b0b60b6e7e1b44d8ddcc
Customs Code: DHA04401196401

Company information

Manufacturer: Abbott Diagnostics Scarborough, Inc.
Manufacturer Country: United States
Authorized Representative: Abbott Rapid Diagnostics Health Corp.

Product details

Intended Use: Limited to the first level identification range of the Measures for the Administration of Medical Devices "Influenza Virus Serum Reagent (C.3330)".
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.3330 流感病毒血清試劑
Import Information: import

Dates and status

Registration Date: Jul 18, 2012
Expiry Date: Jul 18, 2022
Cancellation Date: Apr 12, 2024

Cancellation information

Status: Logged out
Reason: 許可證已逾有效期

About this record

Access comprehensive regulatory information for Baynex Influenza 2-in-1 Viral Antigen Rapid Diagnostic Test Card (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 176e04456a28b0b60b6e7e1b44d8ddcc and manufactured by Abbott Diagnostics Scarborough, Inc.. The authorized representative in Taiwan is Abbott Rapid Diagnostics Health Corp..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.